SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels weaker-than-expected fourth-quarter outlook, slowing PC demand and supply constraints overshadowed better third-quarter results and strong data-center growth, prompting a sharp selloff. Traders debate whether the drop is an overreaction, with bulls citing AI and foundry progress while bears focus on PC weakness, margin pressure and execution risks.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons quarterly results and outlook disappointed investors as heavy AI and data-center spending raised concerns about negative cash flow and returns, pressuring the shares despite accelerating AWS growth. Traders are split between viewing the selloff as an overreaction to a costly investment cycle and worrying that spending may outpace its eventual payoff.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Updated Phase 2 lung-cancer results for lifileucel showed a response rate broadly in line with the prior readout, while a retrospective biomarker-selected subgroup had a higher response rate; Iovance plans to test that subgroup prospectively as it pursues a 2027 filing. The sharp selloff reflects concern that the overall data and immature durability fell short of expectations and that the subgroup and regulatory path remain uncertain, while bullish traders argue the precision-treatment signal is promising and the reaction overdone; many also criticized managements presentation.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddits earnings beat expectations, but weaker Q4 guidance, falling Google search referrals and plans to test logged-in-only access raised concerns about user growth and traffic, driving a sharp selloff. Traders are divided between those who see the login change and AI-driven search shifts as threats to the business and those who view the reaction as excessive given strong revenue growth.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians Q3 results beat expectations and management raised its full-year delivery outlook as R2 production scales, prompting optimism about improving execution and growth. Traders remain divided over the reports muted share-price reaction and ongoing profitability concerns, while speculation about a Walmart van partnership remains unconfirmed.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

Alphabets earnings-related weakness, including slower Search growth and concerns about margins, is weighing on the Magnificent Seven basket. Traders are debating whether this reflects broader risks around AI spending and returns or a temporary pullback, with some seeing an opportunity in the dip.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks quarterly results are driving attention, with stronger comparable sales and an earnings beat supporting the Back to Starbucks turnaround narrative, while a revenue miss and guidance for lower reported revenuelargely tied to the China business restructuringtemper optimism. Traders are divided between viewing store renovations and improving sales as evidence of recovery and questioning whether the business is growing fast enough.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

SLV is drawing attention for a steep selloff after silvers earlier surge, with traders focused on its break below the $50 area and whether further losses lie ahead. Many expect more downside, while others see oversold conditions as a buying opportunity; explanations including rate and yield pressures or alleged shorting remain debated or speculative.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts strong quarterly results and accelerating Azure growth initially lifted sentiment, but the post-earnings rally faded as traders weighed heavy AI infrastructure spending and the bond offering against cash generation. Some attribute the pullback to broader tech weakness and Alphabets selloff, while bullish traders argue Microsoft is converting AI demand into cloud growth and revenue.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNRs selloff is being tied by traders to its Ethereum treasury nearing the 5% accumulation goal, with concern that the buying support could fade as crypto weakness weighs on the stock. Bulls point to its discount to net asset value and call for buybacks, while critics question managements forecasts and the stocks weak performance relative to ETH.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IWMs relative resilience as mega-cap technology stocks sell off has fueled talk of rotation into small caps. Traders debate whether improving small-cap strength can continue or is temporary, with elevated oil prices, interest-rate uncertainty and broader risk concerns cited as headwinds.

PHAT Stock Eyes Worst Day In Nearly Two Years After Generic Drug Maker Challenges Key Drug’s Exclusivity

Equity

Phathom said BDR Pharmaceuticals International Pvt. Ltd. filed suit in the U.S. District Court for the District of Columbia against the FDA and related federal defendants.


SharpLink CEO Says Mag 7 Stocks Could Be Tokenized ‘Sooner Than We Think’ Despite CLARITY Act Stalemate

According to him, tokenization of the Magnificent Seven stocks could "fundamentally transform” markets.


RAPP Stock Tempers Premarket Gains On Concerns Over Higher Discontinuation Rates In Bipolar Mania Study

The drug met its primary trial goal, producing a statistically significant 3.1-point improvement over placebo on a standard clinician-rated scale that measures the severity of manic symptoms.


LION Stock Rallies As Dune Producer Reportedly Puts Offer On The Table For The Hunger Games Studio

Legendary, the producer of the Dune and Minecraft film franchises, has submitted a formal takeover offer for Lionsgate, Bloomberg reported. 


Omeros Shares Slide After CHMP Upholds Negative Opinion On Drug; Analyst Sees Buying Opportunity At $16

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a negative opinion on Omeros’ marketing authorization application for narsoplimab, sold as Yartemlea in the United States, the company said on Friday. 


S&P 500 Bull Market Has Reasons For Optimism, Says Baird — But Higher Rates Could Favor Quality Stocks

Six of the seven previous bull markets that reached their fourth anniversary posted positive fifth-year returns, with an average gain of 13.4% across all seven, according to Baird.

CIFR Stock On Track To Hit 6-Month Low After Cipher Digital Plans To Sell $850M Convertible Notes 

Cipher is also seeking to swap part of its 1.75% notes due 2030 for ordinary shares, which might result in more shares being issued and could put more pressure on CIFR stock.

BMBL Stock Soars Over 50% On $1B Take-Private Talks; MTCH Edges Higher As Well

The prospective buyer for Bumble is Ithaca Holdings, a recently formed firm led by two Silicon Valley executives, the Wall Street Journal reported. 


BULL Stock Heads For Biggest Drop In Over A Year After House Panel Reportedly Flags Webull’s ‘Structural’ Ties To China

According to a CNBC report, the panel raised concerns about Webull’s software, data pipelines, and engineering infrastructure.

Strive's Matt Cole Says Bitcoin Could Hit $500,000 By The End Of 2030 

Matt Cole expects a new Bitcoin bull market within the next 18 months, driven by a weaker dollar.


iShares Trust - iShares Russell 2000 Index Fund

Extremely Bearish Sentiment

<ul class="summary-bullets"><li>BDR is principally challenging the FDA’s alleged refusal to accept an abbreviated new drug application referencing Phathom’s new drug application for VOQUEZNA tablets.&nbsp;</li><li>Phathom said it is reviewing BDR’s filings but believes the FDA carefully and correctly evaluated the issue when it recognized the drug’s exclusivity until 2032.&nbsp;</li><li>The company stated it “intends to take appropriate action to protect its statutory exclusivities.”</li></ul>Shares of Phathom Pharmaceuticals (PHAT) plunged roughly 23% on Friday after the company disclosed that BDR Pharmaceuticals had sued the U.S. Food and Drug Administration over exclusivity for its key drug VOQUEZNA.Phathom said BDR Pharmaceuticals International Pvt. Ltd. filed suit in the U.S. District Court for the District of Columbia against the FDA and related federal defendants. BDR is principally challenging the FDA’s alleged refusal to accept an abbreviated new drug application (ANDA)—the pathway for a generic version—referencing Phathom’s new drug application for VOQUEZNA tablets.BDR claims the FDA improperly applied laws to extend Phathom’s drug’s exclusivity. The stock is now on track for its worst day since November 2024, if the losses hold.<h2 class="st-heading-2">VOQUEZNA Market And Exclusivity</h2>VOQUEZNA is used for heartburn related to non-erosive gastroesophageal reflux disease (GERD), healing and maintenance of erosive GERD, and as a combination for H. pylori infection. The drug was first approved in May 2022 and later for other indications. The drug carries 10 years of exclusivity and protection against generic versions, until May 2032.Phathom said it is reviewing BDR’s filings but believes the FDA carefully and correctly evaluated the issue when it recognized the drug’s exclusivity until 2032. The company stated it “intends to take appropriate action to protect its statutory exclusivities.” An adverse outcome could shorten exclusivity, allow earlier ANDA acceptance and potential approval, and pressure VOQUEZNA sales, the stock price, and overall business prospects.<h2 class="st-heading-2">Wall Street Weighs In On PHAT</h2>Cantor Fitzgerald acknowledged that ongoing lawsuits can create overhangs for stocks. However, the firm sees a low likelihood that the FDA will reverse its decision and estimates Phathom still has more than six years of selling VOQUEZNA without competition. Cantor maintained its ‘Overweight’ rating on the shares.Phathom Pharmaceuticals reported $175.1 million in net revenue for full-year 2025. This was a 217% increase from $55.3 million in 2024, and essentially all came from sales of its VOQUEZNA franchise.<h2 class="st-heading-2">How Did PHAT Retail Traders React?</h2>On Stocktwits, retail sentiment around <a class="mention" data-mention="$PHAT" data-symbol-id="PHAT" href="https://stocktwits.com/symbol/PHAT" target="_blank">PHAT stock</a> jumped from 'bearish' to 'extremely bullish' territory over the past 24 hours, while message volume rose from 'low' to 'extremely high' levels.A Stocktwits user highlighted that the lawsuit is not confirmation of generic competition.<stembedurl>https://stocktwits.com/Mungermind/message/667242289</stembedurl>Another user said that the lawsuit will have little impact besides causing the selloff, as the FDA will not allow generics for the drug.<stembedurl>https://stocktwits.com/Canvasback33/message/667239660</stembedurl><a href="https://stocktwits.com/symbol/PHAT">PHAT stock </a>has dropped 67% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/iovance-s-melanoma-therapy-shows-promising-4-year-data-retail-says-acquisition-imminent-before-2027-end/cZxyVmpRBxw">Iovance’s Melanoma Therapy Shows Promising 4-Year Data – Retail Says Acquisition Imminent Before 2027-End</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

In this photo illustration, the Phathom Pharmaceuticals' logo is displayed on the screen of a smart tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Phathom said BDR Pharmaceuticals International Pvt. Ltd. filed suit in the U.S. District Court for the District of Columbia against the FDA and related federal defendants.

iShares Russell 2000 ETF

Phathom Pharmaceuticals Inc

Vanguard Total Stock Market ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Small cap stocks are demonstrating significant relative strength and breakout potential, attracting investors rotating out of large cap tech.

Traders are actively moving capital between defensive and high-beta assets as volatility intensifies around earnings and the Fed.

Investors are hyper-focused on interest rate holds and Warsh's commentary as the primary catalysts for near-term market direction.

Mega-cap tech sentiment is shifting negatively due to disappointing quarterly guidance and questions regarding high AI spending.

Rising tensions in the Middle East and concerns over potential military campaigns are driving volatility across equity and energy markets.

Current Price	$284.01
Prev Close	$281.29
Open	$282.41
Dividend Yield	N/A
50-Day Moving Average	$284.64
Beta	N/A
Avg. Volume	23.07M
PE Ratio	N/A

52-Week High	$305.18
52-Week Low	$228.90
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

IWM Fundamentals